Home Press Releases Recombinant Proteins Market Size Worth $5.04 Billion By 2030 | CAGR: 12.0%

Recombinant Proteins Market Size Worth $5.04 Billion By 2030 | CAGR: 12.0%

The global recombinant proteins market size is expected to reach USD 5.04 billion by 2030, according to a new study by Polaris Market Research. The report Recombinant Proteins Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Product, Production Services); By Application; By End-Use; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

 

A significant increase in government funding, increased R&D spending by pharmaceutical companies, and increasing non-communicable and chronic illnesses is expected to drive demand. Furthermore, the availability of a diverse range of innovations from human and animal sources and the rising demand for biological products is expected to drive industry growth.

 

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/recombinant-proteins-market/request-for-sample

 

In addition, other factors that are expected to complement growth opportunities include growing interest in personalized medicine and protein therapeutics. Several countries in Asia Pacific, including India, China, Japan, and South Korea, are likely to influence industry growth positively. However, decreasing the cost of the product may have some limitations, likely restraining industry growth.

 

The COVID-19 pandemic benefited the industry due very high number of coronavirus infections. It has allowed several research units to develop various combinations of recombination protein subunits, leading to a huge rise in demand for the product.

 

Recombinant Proteins Market Report Highlights

  • The demand for the therapeutics segment is expected to drive the revenue growth as demand for effective and convenient treatments is expected to witness growth over the forecast period
  • The enzymes segment accounted for the highest revenue share in 2021 and is expected to continue its dominance owing to the usage of enzymes in many research domains such as wound repairs, oncology, and other diseases
  • The pharmaceutical & biotech companies segment is expected to spearhead revenue growth to forecast and diagnose drug research more frequently
  • Asia Pacific is expected to witness substantial growth over the forecast period on account of several non-curable illnesses that are increasing across developing economies like India and China with increasing R&D initiatives
  • Major players operating in the industry include Abcam plc, Abnova Corp, Aviva systems biology, Bio-Techne corporation, Bio-Rad laboratories, Elpiscience, Elevian inc, Eli Lilly and co, Enzo life sciences, Inc, Gigagen inc, Genscript, Janssen-Cilag pty ltd, Merck KGaA, Proteinrech Group, Inc, R&D System, Inc, Raybiotech Life Inc., Stemcell Technologies Inc, Sino Biological Inc, Thermo Fisher Scientific, and U Protein Express

 

Polaris Market Research has segmented the recombinant proteins market report based on product & services, application, end-use, and region:

 

Recombinant Proteins, Product & Services Outlook (Revenue – USD Billion, 2018 – 2030)

  • Product
    • Cytokines & Growth Factors
      • Interferons (IFNs)
      • Interleukins (ILs)
      • Others
    • Antibodies
    • Immune Checkpoint Proteins
    • Virus Antigens
    • Enzymes
      • Kinases
      • Metabolic Enzymes
      • Others
    • Recombinant Regulatory Proteins
    • Hormones
    • Others
  • Production Services

Recombinant Proteins, Application Outlook (Revenue – USD Billion, 2018 – 2030)

  • Drug Discovery & Development
  • Therapeutics
    • Biologics
    • Vaccines
    • Cell & Gene Therapies
    • Others
  • Research
  • Others

Recombinant Proteins, End-Use Outlook (Revenue – USD Billion, 2018 – 2030)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Others

Recombinant Proteins, Regional Outlook (Revenue – USD Billion, 2018 – 2030)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

License and Pricing

Buy Now

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing

Request For Customization

Please specify your research requirement and get customized report


Regional AnalysisSegmentation AnalysisIndustry OutlookCompetitive Analysis
By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

By using this form you agree with the storage and handling of your data by this website.